Eprosartan dihydate and a process for its production and formulation
US6420412B2 · kind B2 · utility
5Cited by
1References
41Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 15, 2001 |
| Grant date | Jul 16, 2002 |
| Priority date | — |
| Expiry date | Mar 15, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/556
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to (E)-&agr;-[2-n-butyl-1-[(4-carboxyphenyl)methyl]-1-H-imidazol-5-yl]methylene-2-thiopheneproprionic acid monomethanesulfonate dihydrate, a process for its production, compositions containing the compound and methods of using the compound to block angiotensin II receptors and to treat hypertension, congestive heart failure and renal failure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.